{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T22:41:25Z","timestamp":1775169685283,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Obstetrics and Gynecology Clinics of North America"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.ogc.2011.12.003","type":"journal-article","created":{"date-parts":[[2012,1,5]],"date-time":"2012-01-05T17:08:33Z","timestamp":1325783313000},"page":"77-87","source":"Crossref","is-referenced-by-count":32,"title":["Tocolytic Therapy for Acute Preterm Labor"],"prefix":"10.1016","volume":"39","author":[{"given":"Adi","family":"Abramovici","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Cantu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheri M.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ogc.2011.12.003_bib1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/GCO.0b013e3283292455","article-title":"Prematurity prevention: the role of acute tocolysis","volume":"21","author":"Blumenfeld","year":"2009","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.12.003_bib2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-2393-9-42","article-title":"Assessment of perinatal outcome after sustained tocolysis in early labour (APOSTEL-II trial)","volume":"9","author":"Roos","year":"2009","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ogc.2011.12.003_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(08)60074-4","article-title":"Epidemiology and causes of preterm birth","volume":"371","author":"Goldenberg","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ogc.2011.12.003_bib4","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0002-9378(99)70111-0","article-title":"The preterm prediction study: effect of gestational age and cause of preterm birth on subsequent obstetric outcome","volume":"181","author":"Mercer","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.12.003_bib5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1067\/mob.2003.41","article-title":"Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study","volume":"188","author":"da Fonseca","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.12.003_bib6","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa035140","article-title":"Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate","volume":"348","author":"Meis","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ogc.2011.12.003_bib7","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJM200005183422007","article-title":"Intrauterine infection and preterm delivery","volume":"342","author":"Goldenberg","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ogc.2011.12.003_bib8","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0029-7844(99)00329-4","article-title":"Tocolytics for preterm labor: a systematic review","volume":"94","author":"Gyetvai","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.12.003_bib9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1471-0528.1998.tb10156.x","article-title":"Optimising maternal-fetal outcomes in preterm labour: a decision analysis","volume":"105","author":"Macones","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ogc.2011.12.003_bib10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/AOG.0b013e31817c50fc","article-title":"Obstetrician-gynecologists' screening and management of preterm birth","volume":"112","author":"Morgan","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.12.003_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-9378(77)90808-0","article-title":"A comparison of magnesium sulfate and alcohol for the prevention of premature labor","volume":"129","author":"Steer","year":"1977","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.12.003_bib12","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/ajcp\/102.5.616","article-title":"Magnesium: the fifth but forgotten electrolyte","volume":"102","author":"Elin","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ogc.2011.12.003_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0098-2997(02)00088-2","article-title":"Cell physiology of magnesium","volume":"24","author":"Wolf","year":"2003","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.ogc.2011.12.003_bib14","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.ajog.2005.11.045","article-title":"Effect of magnesium sulfate on contractile force and intracellular calcium concentration in pregnant human myometrium","volume":"194","author":"Fomin","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.12.003_bib15","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1006\/bbrc.1998.9680","article-title":"Cellular mechanisms underlying magnesium sulfate inhibition of phasic myometrial contractions","volume":"252","author":"Phillippe","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ogc.2011.12.003_bib16","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/AOG.0b013e3181b48336","article-title":"Magnesium sulfate for preterm labor and preterm birth","volume":"114","author":"Mercer","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.12.003_bib17","author":"Simhan"},{"key":"10.1016\/j.ogc.2011.12.003_bib18","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1067\/mob.2000.107334","article-title":"A prospective, randomized, controlled trial of high and low maintenance doses of magnesium sulfate for acute tocolysis","volume":"182","author":"Terrone","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.12.003_bib19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/01.AOG.0000269048.06634.35","article-title":"Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor: a randomized controlled trial","volume":"110","author":"Lyell","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.12.003_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/AOG.0b013e3181c4f7c1","article-title":"Effects of magnesium sulfate on preterm fetal cerebral blood flow using Doppler analysis: a randomized controlled trial","volume":"115","author":"Twickler","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.12.003_bib21","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1542\/peds.47.3.501","article-title":"The clinical and biochemical effects of excess magnesium in the newborn","volume":"47","author":"Lipsitz","year":"1971","journal-title":"Pediatrics"},{"key":"10.1016\/j.ogc.2011.12.003_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001060","article-title":"Magnesium sulphate for preventing preterm birth in threatened preterm labour","volume":"4","author":"Crowther","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ogc.2011.12.003_bib23","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1001\/jama.290.20.2669","article-title":"Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial","volume":"290","author":"Crowther","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ogc.2011.12.003_bib24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1542\/peds.2007-2971","article-title":"Benefit of magnesium sulfate given before very preterm birth to protect infant brain","volume":"121","author":"Marret","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.ogc.2011.12.003_bib25","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJMoa0801187","article-title":"A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy","volume":"359","author":"Rouse","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ogc.2011.12.003_bib26","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/bmj.3.5767.144","article-title":"Results of double-blind, multicentre study with ritodrine in premature labour","volume":"3","author":"Wesselius-de Casparis","year":"1971","journal-title":"Br Med J"},{"key":"10.1016\/j.ogc.2011.12.003_bib27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1471-0528.1977.tb12461.x","article-title":"A trial of oral ritodrine for the prevention of premature labour","volume":"84","author":"Walters","year":"1977","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ogc.2011.12.003_bib28","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0002-9378(77)90115-6","article-title":"Inhibition of premature labor: a multicenter comparison of ritodrine and ethanol","volume":"127","author":"Lauersen","year":"1977","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.12.003_bib30","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1056\/NEJMra050435","article-title":"Prevention of preterm delivery","volume":"357","author":"Simhan","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ogc.2011.12.003_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004352.pub2","article-title":"Betamimetics for inhibiting preterm labour","volume":"4","author":"Anotayanonth","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ogc.2011.12.003_bib32","doi-asserted-by":"crossref","first-page":"134.e1","DOI":"10.1016\/j.ajog.2010.11.038","article-title":"Nifedipine in the management of preterm labor: a systematic review and metaanalysis","volume":"204","author":"Conde-Agudelo","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.12.003_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0002-9378(84)80101-5","article-title":"A double-blind study comparing ritodrine and terbutaline in the treatment of preterm labor","volume":"150","author":"Caritis","year":"1984","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.12.003_bib34","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/0002-9378(85)90397-7","article-title":"Tocolytic and hemodynamic effects of nifedipine in the ewe","volume":"151","author":"Golichowski","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.12.003_bib35","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0002-9378(12)80004-4","article-title":"Neonatal periventricular-intraventricular hemorrhage after maternal beta-sympathomimetic tocolysis","volume":"167","author":"Groome","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.12.003_bib36","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0029-7844(99)00596-7","article-title":"Neonatal effects of nifedipine and ritodrine for preterm labor","volume":"95","author":"Papatsonis","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.12.003_bib37","doi-asserted-by":"crossref","first-page":"F13","DOI":"10.1136\/fn.85.1.F13","article-title":"Effect of maternal tocolysis on the incidence of severe periventricular\/intraventricular haemorrhage in very low birthweight infants","volume":"85","author":"Weintraub","year":"2001","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.ogc.2011.12.003_bib38","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000292378","article-title":"Ritodrine tocolysis and neonatal intraventricular-periventricular hemorrhage","volume":"39","author":"Ozcan","year":"1995","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ogc.2011.12.003_bib39","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-2007-993904","article-title":"Association of tocolytic therapy with antenatal steroid administration and infant outcomes","volume":"15","author":"Palta","year":"1998","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ogc.2011.12.003_bib40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-0030-1262512","article-title":"Calcium channel blockers for the management of preterm birth: a review","volume":"28","author":"Nassar","year":"2011","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ogc.2011.12.003_bib41","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/0002-9378(89)90403-1","article-title":"Cardiovascular and metabolic effects associated with nifedipine and ritodrine tocolysis","volume":"161","author":"Ferguson","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.12.003_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001992.pub2","article-title":"Cyclo-oxygenase (COX) inhibitors for treating preterm labour","author":"King","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ogc.2011.12.003_bib43","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0029-7844(03)00395-8","article-title":"Management of preterm labor","volume":"101","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.12.003_bib44","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/AOG.0b013e318199924a","article-title":"Tocolytic therapy: a meta-analysis and decision analysis","volume":"113","author":"Haas","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.12.003_bib45","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1055\/s-2007-976546","article-title":"The safety of prolonged indomethacin therapy","volume":"24","author":"Savage","year":"2007","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ogc.2011.12.003_bib46","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJM198808113190602","article-title":"Indomethacin in the treatment of premature labor","volume":"319","author":"Moise","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ogc.2011.12.003_bib47","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0002-9378(97)70184-4","article-title":"The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational age","volume":"177","author":"Vermillion","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.12.003_bib48","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.ajog.2004.12.036","article-title":"The effect of short-term indomethacin therapy on amniotic fluid volume","volume":"192","author":"Sandruck","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.12.003_bib49","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/01.AOG.0000168622.56478.df","article-title":"Assessing the neonatal safety of indomethacin tocolysis: a systematic review with meta-analysis","volume":"106","author":"Loe","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.12.003_bib50","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3109\/00016348509156728","article-title":"The effect on the human uterus of two newly developed competitive inhibitors of oxytocin and vasopressin","volume":"64","author":"Akerlund","year":"1985","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ogc.2011.12.003_bib51","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1095\/biolreprod60.2.322","article-title":"Effect of oxytocin receptor and beta2-adrenoceptor blockade on myometrial oxytocin receptors in parturient rats","volume":"60","author":"Engstr\u00f8m","year":"1999","journal-title":"Biol Reprod"},{"key":"10.1016\/j.ogc.2011.12.003_bib52","first-page":"RA268","article-title":"Oxytocin antagonists for tocolysis in preterm labour: a systematic review","volume":"8","author":"Coomarasamy","year":"2002","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.ogc.2011.12.003_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004452.pub2","article-title":"Oxytocin receptor antagonists for inhibiting preterm labour","volume":"3","author":"Papatsonis","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ogc.2011.12.003_bib54","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejogrb.2005.12.010","article-title":"Atosiban and nifedipine in acute tocolysis: a comparative study","volume":"128","author":"Al-Omari","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ogc.2011.12.003_bib55","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijgo.2005.06.005","article-title":"Atosiban and nifedipine for the treatment of preterm labor","volume":"91","author":"Kashanian","year":"2005","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ogc.2011.12.003_bib56","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1034\/j.1600-0412.2001.d01-456.x","article-title":"The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor","volume":"80","year":"2001","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ogc.2011.12.003_bib57","first-page":"133","article-title":"Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour","volume":"108","year":"2001","journal-title":"BJOG"},{"key":"10.1016\/j.ogc.2011.12.003_bib58","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/0002-9378(95)90365-8","article-title":"The pharmacokinetics of the oxytocin antagonist atosiban in pregnant women with preterm uterine contractions","volume":"173","author":"Goodwin","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.12.003_bib59","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/0002-9378(95)91497-8","article-title":"Placental passage of the oxytocin antagonist atosiban","volume":"172","author":"Valenzuela","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.12.003_bib60","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0002-9378(93)90023-C","article-title":"Maternal and fetal cardiovascular effects and placental transfer of the oxytocin antagonist atosiban in late-gestation pregnant sheep","volume":"169","author":"Greig","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.12.003_bib61","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1067\/mob.2000.104950","article-title":"Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study","volume":"182","author":"Moutquin","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.12.003_bib62","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-2007-994312","article-title":"Treatment of preterm labor with the oxytocin antagonist atosiban","volume":"13","author":"Goodwin","year":"1996","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ogc.2011.12.003_bib63","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1067\/mob.2000.95834","article-title":"An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue","volume":"182","author":"Romero","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.12.003_bib64","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2147\/IJWH.S7219","article-title":"Management of preterm labor: atosiban or nifedipine?","volume":"2","author":"de Heus","year":"2010","journal-title":"Int J Womens Health"}],"container-title":["Obstetrics and Gynecology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854511001264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854511001264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T19:02:52Z","timestamp":1640372572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889854511001264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0889854511001264"],"URL":"https:\/\/doi.org\/10.1016\/j.ogc.2011.12.003","relation":{},"ISSN":["0889-8545"],"issn-type":[{"value":"0889-8545","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}